These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 114392)
1. Purification and some characteristics of the human coagulation factor VII. Flengsrud R Eur J Biochem; 1979 Aug; 98(2):455-64. PubMed ID: 114392 [TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of bovine factor VII. Kisiel W; Davie EW Biochemistry; 1975 Nov; 14(22):4928-34. PubMed ID: 1182130 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. Bajaj SP; Rapaport SI; Brown SF J Biol Chem; 1981 Jan; 256(1):253-9. PubMed ID: 6778860 [TBL] [Abstract][Full Text] [Related]
4. Purification of human factor VII utilizing O-(diethylaminoethyl)-Sephadex and Sulfopropyl-Sephadex chromatography. Rao LV; Bajaj SP Anal Biochem; 1984 Feb; 136(2):357-61. PubMed ID: 6609650 [TBL] [Abstract][Full Text] [Related]
5. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin. Bajaj SP; Rapaport SI; Maki SL; Brown SF Prep Biochem; 1983; 13(3):191-214. PubMed ID: 6226944 [TBL] [Abstract][Full Text] [Related]
6. The purification of human factor II (prothrombin) and the preparation of a specific antiserum. Heystek J; Maier van den Zande GM; Brummelhuis HG; Krijnen HW Vox Sang; 1974; 27(3):214-26. PubMed ID: 4213473 [No Abstract] [Full Text] [Related]
7. A method for systematic purification from bovine plasma of six vitamin K-dependent coagulation factors: prothrombin, factor X, factor IX, protein S, protein C, and protein Z. Hashimoto N; Morita T; Iwanaga S J Biochem; 1985 May; 97(5):1347-55. PubMed ID: 3161875 [TBL] [Abstract][Full Text] [Related]
9. Application of factor VII-Sepharose affinity chromatography in the purification of human tissue factor apoprotein. Bom VJ; Ram IE; Alderkamp GH; Reinalda-Poot HH; Bertina RM Thromb Res; 1986 Jun; 42(5):635-43. PubMed ID: 3715822 [TBL] [Abstract][Full Text] [Related]
10. Purification and properties of the phenprocoumon-induced decarboxyfactor X from bovine plasma. A comparison to normal factor X. Lindhout MJ; Kop-Klaassen BH; Kop JM; Hemker HC Biochim Biophys Acta; 1978 Apr; 533(2):302-17. PubMed ID: 417733 [TBL] [Abstract][Full Text] [Related]
11. STUDIES ON PROCONVERTIN (FACTOR VII). VI. THE PRODUCTION IN RABBITS OF AN ANTISERUM AGAINST FACTOR VII. PRYDZ H Scand J Clin Lab Invest; 1965; 17():66-72. PubMed ID: 14260936 [No Abstract] [Full Text] [Related]
12. Human coagulation factor IX. Isolation and characterization. Suomela H Eur J Biochem; 1976 Dec; 71(1):145-54. PubMed ID: 827443 [TBL] [Abstract][Full Text] [Related]
13. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor. Nemerson Y; Esnouf MP Proc Natl Acad Sci U S A; 1973 Feb; 70(2):310-4. PubMed ID: 4510277 [TBL] [Abstract][Full Text] [Related]
14. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing. Pechet L; Smith JA Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341 [No Abstract] [Full Text] [Related]
15. Purification and properties of human coagulation factor VII. Broze GJ; Majerus PW J Biol Chem; 1980 Feb; 255(4):1242-7. PubMed ID: 7354023 [TBL] [Abstract][Full Text] [Related]
16. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems. Saito H; Ratnoff OD J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996 [TBL] [Abstract][Full Text] [Related]
17. Immunoaffinity purification of bovine factor VII. Bach R; Oberdick J; Nemerson Y Blood; 1984 Feb; 63(2):393-8. PubMed ID: 6362751 [TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of bovine factor XI (plasma thromboplastin antecedent). Koide T; Kato H; Davie EW Biochemistry; 1977 May; 16(10):2279-86. PubMed ID: 861211 [TBL] [Abstract][Full Text] [Related]
19. Purification and heterogeneity of human kininogen. Use of DEAE-chromatography, molecular sieving and antibody specific immunosorbents. Hamberg U; Elg P; Nissinen E; Stelwagen P Int J Pept Protein Res; 1975; 7(3):261-80. PubMed ID: 1158563 [TBL] [Abstract][Full Text] [Related]
20. The preparation and properties of factor V from bovine plasma. Chulkova T; Hernandez G Clin Chim Acta; 1975 Jul; 62(1):21-8. PubMed ID: 1149279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]